Skip to content

Jonathan L. Halperin

Mount Sinai Hospital

2 papers in the Anchorcite directory, published between 2011 and 2013, cited 14,788 times in total.

ORCID profile

Research topics

Frequent co-authors

Papers

  1. Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine · 2011 · 9,529 citations

    BACKGROUND: The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor Xa inhibitor, may provide more consistent and predictable anticoagulation than warfarin. METHODS: In…

  2. Edoxaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2013 · 5,259 citations

    BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. METHODS: We conducted a randomized, double-blind, double-dummy trial…

Metadata from OpenAlex (CC0).